Incidence of Intrahepatic Cholestasis of Pregnancy and Its Impact on Maternal and Neonatal Outcomes: A Systematic Review and Meta-Analysis
Background: This study employed a meta-analysis approach to investigate the incidence of intrahepatic cholestasis of pregnancy (ICP) and its impact on adverse outcomes in both pregnant and postpartum women, as well as neonates. Me...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-06-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/52/6/10.31083/CEOG37850 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background: This study employed a meta-analysis approach to investigate the incidence of intrahepatic cholestasis of pregnancy (ICP) and its impact on adverse outcomes in both pregnant and postpartum women, as well as neonates. Methods: We obtained studies published from the inception of the PubMed, Cochrane Library, and Web of Science databases through January 2024. A total of 21 original articles were included, reporting on ICP and its associated adverse outcomes in maternal and neonatal populations. The included studies involved 1,497,951 controls non-intrahepatic cholestasis of pregnancy (non-ICP) and 12,262 ICP patients. Sensitivity analyses and evaluations for publication bias were also conducted. Results: The pooled analysis estimated an ICP incidence of 3% (95% confidence interval [CI], 1%–7%), while the meta-analysis demonstrated the following risk ratios: postpartum hemorrhage showed a relative risk (RR, 0.82; 95% CI, 0.69–0.99), whereas significant increases were observed for preeclampsia (RR, 2.39; 95% CI, 2.21–2.59), Cesarean section (RR, 1.28; 95% CI, 1.15–1.42), preterm birth (RR, 2.71; 95% CI, 1.77–4.15), and maternal infection (RR, 3.22; 95% CI, 2.48–4.19). Other outcomes included labor induction (RR, 1.60; 95% CI, 0.51–4.99), gestational diabetes mellitus (GDM; RR, 1.29; 95% CI, 0.83–2.01), stillbirth (RR, 1.25; 95% CI, 0.64–2.42), and small for gestational age (SGA; RR, 1.06; 95% CI, 0.71–1.57), which were not statistically significant. Neonatal intensive care unit (NICU) admission (RR, 1.79; 95% CI, 1.35–2.37), with a significant increase in risk. Conclusions: This meta-analysis demonstrates a global incidence of ICP at 3% and identifies significant associations with adverse maternal and neonatal outcomes. ICP is associated with increased risks of preeclampsia, Cesarean section, preterm birth, maternal infection, and neonatal intensive care needs. Interestingly, a relative risk of postpartum hemorrhage was observed, suggesting the need for further investigation into the underlying mechanisms. Although labor induction, GDM, and stillbirth showed non-significant trends toward increased risk, their clinical relevance persists. These findings underscore the necessity for risk-stratified surveillance in ICP management, emphasizing infection control and preterm prevention, alongside regionally tailored clinical protocols. Registration: The study has been registered on https://inplasy.com/inplasy-2025-3-0132/ (registration number: INPLASY202530132). |
|---|---|
| ISSN: | 0390-6663 |